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Specialist in Blood Banking (SBB) programs play an important role 
in preparing technologists to become leaders and contributors to 
the field of transfusion medicine through dedicated education and 
training. The SBB program at the National Institutes of Health 
(NIH) Clinical Center has graduated 55 students since 1994 with 
an overall pass rate of 96 percent for the American Society for 
Clinical Pathology (ASCP) SBB examination. Graduates hold 
positions in a variety of transfusion medicine–related fields, 
with hospitals, blood centers, and Immunohematology Reference 
Laboratories being the most common categories of employer. 
Projects completed as part of the program added to transfusion 
medicine knowledge as evidenced by publications and awards. 
Almost half of all projects completed led to publications (49%), 
and greater than 50 percent of submissions have been selected 
for the AABB Future Leaders Scholarship (previously known as 
AABB Fenwal Scholarship Award). The students have completed 
over 40 program value-added opportunities. This information 
was available for retrieval and review. In this review, we analyzed 
data for the last 25 years from the SBB program at the NIH Clinical 
Center on program statistics, student accomplishments (such as 
publications in peer-reviewed journals), program value-added 
opportunities (such as other publications and audits performed 
with our Quality Assurance office), and job procurement. The 
collected, reviewed, and organized data provided a useful internal 
self-assessment to review the history of our program and head 
into the future. Immunohematology 2020;36:7–13.
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Introduction
Specialist in Blood Banking (SBB) programs provide 
comprehensive training in all phases of blood banking and 
are accredited by the Commission on Accreditation of Allied 
Health Education Programs (CAAHEP). After successful 
completion of an accredited SBB program, graduates are eligible 
to take the SBB examination sponsored by the American 
Society for Clinical Pathology (ASCP) Board of Certification to 
receive SBB certification.1
Accredited SBB programs must adhere to the Standards 
and Guidelines adopted by the AABB and CAAHEP.2 To 
ensure meeting these rules, inspectors representing AABB 
and CAAHEP assess SBB programs on a routine basis. The 
curriculum must adhere to the Standards and Guidelines, 
and each SBB program then develops teaching methods that 
address the three domains of learning and provides evidence 
of competency by students.2
On an annual basis, each program is required to complete 
and submit a report to the accrediting body.1 This report is 
outcome-based, identifying five outcomes: (1) graduation rate, 
(2) SBB certification rate, (3) career advancement, (4) employer 
survey return rate and satisfaction, and (5) graduate survey 
return rate and satisfaction. Each program must document 
evidence for conducting regular internal reviews. Internal 
review results may indicate a need for improvement to the 
program. Thresholds have been determined for each outcome, 
and program managers must develop a correction plan when 
a program does not meet a threshold. AABB’s Committee on 
Accreditation reviews these reports and correction plans and 
provides feedback allowing for ongoing process improvement.
With continuous advancements in transfusion medicine, 
educational programs such as SBB programs and Transfusion 
Medicine fellowship programs may benefit from a periodic 
internal review of their program’s performance. This type 
of review provides data to analyze and determine distinct 
characteristics and attributes of their program. When data are 
available for review, managers can acknowledge successful 
team members, identify strengths and weaknesses, and 
recognize areas for improvement. This retrospective review 
from 1994 to the present analyzes outcomes of the SBB 
program at the National Institutes of Health (NIH).
Materials and Methods
Data were collected from paper documents, electronic 
records, and PubMed searches, and results were organized into 
three categories: program statistics, student accomplishments, 
and program value-added opportunities. Program statistics 
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included enrollment and attrition of students and passing 
rates of the SBB certification examination offered by ASCP 
Board of Certification. Student accomplishments included 
positive professional placement, submission and receipt of 
scholarships, and publications in peer-reviewed journals as 
a direct result of a student project. To obtain a broad view of 
the variety of student projects performed, we sorted projects 
into one of nine topics, which were modeled after the table of 
content categories used by the journal Transfusion, and we 
added a few subtopics for clarity. We tabulated program value-
added opportunities, such as group and quality assurance 
projects, completed during the 1-year program that promoted 
team building, auditing, writing, and presentation skills. We 
retrieved publications in peer-reviewed journals authored by 
graduates to determine contributions made to the transfusion 
medicine body of knowledge post-graduation.
We collated data for this review until October 2019. 
Tracking graduates over time was difficult, and we could not 
collect or confirm some information regarding career choices 
or current employment status. Because our evaluation includes 
students who graduated in 2019, reporting of publications may 




Student enrollment and graduation rates for the last 25 
years were consistent, with an average of two graduates per 
year. The overall ASCP examination pass rate was 96 percent 
(Table 1).
Career Advancement, Scholarships, and Satisfaction 
Surveys
NIH graduates were able to find positions, most being 
employed at hospitals, blood centers, or Immunohematology 
References Laboratories (IRLs) (Table 2). Submission for the 
AABB Future Leaders Scholarship (previously known as 
AABB Fenwal Scholarship Award) is above 80 percent, with 
more than half of our submissions resulting in receipt of an 
award (Table 3). We initially had few submissions for the 
Suzanne Ledin Travel Award, inaugurated in 2006 (Table 3). 
In the last 5 years, however, four submissions resulted in three 
awards. Return and satisfaction rates of both employer and 
graduate surveys exceeded the 50 percent threshold, expected 
by the AABB’s Committee of Accreditation, and had acceptable 
ratings (data not shown).
Student Research Projects and Other Opportunities
Close to 50 percent of student projects are published 
(Table 4).3–29 Transfusion practices and immunohematology 
were most common topics for SBB projects (Table 5). More 
than half of the student projects (Table 6) were sponsored 
by one of the five departmental sections. Over 40 program 
Table 1. Enrollment, attrition, and pass rates for students in the 
SBB program at the NIH Clinical Center, 1994–2019




Passed first attempt 46
Passed ≥ two attempts 6
Did not pass 2
Did not attempt 1
*24 graduating classes; no classes enrolled in 2003 and 2008.
†Overall pass rate was 96% of those who attempted.
SBB = Specialist in Blood Banking; NIH = National Institutes of Health.
Table 2. Career positions in 2019 for SBB graduates from the NIH 
program, 1994–2019
Area of employment SBB graduates (N)
Hospitals, blood centers, or IRLs 27
Regulatory/quality assurance 10
Transplantation and cellular engineering 3
Industry 3
Education 3
Unrelated to blood banking 2
Not currently employed 0
Unable to confirm 5
Retired 2
Total 55
SBB = Specialist in Blood Banking; NIH = National Institutes of Health; 
IRLs = Immunohematology Reference Laboratories.
Table 3. Scholarship awards for SBB graduates from the NIH 
program, 1994–2019










55 46 (84) 24 (52) 8 of 28 (29) 3 of 8 (38)
*Initiated in 2006.
SBB = Specialist in Blood Banking; NIH = National Institutes of Health.
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value-added opportunities have been completed in 25 years 
(Table 7).30–49 The variety of topics covered most areas in 
transfusion medicine.
Table 4. Publication record for SBB graduates from the NIH 
program, 1994–2019*
SBB projects N % References
All SBB projects 55 100 NA
With publications† 27 49 3–28
As first authors 21 78 3,5–11,13–17,19,20,23–29
*Based on graduation date.
†SBB student projects resulting in a publication.
SBB = Specialist in Blood Banking; NIH = National Institutes of Health;  
NA = not applicable.
Table 5. SBB projects and topics for SBB graduates from the NIH 
program, 1994–2019*
Project topic SBB projects (N)
Laboratory practices 14
Immunohematology 11
Blood group genomics 8
Transplantation and cellular engineering 6
Education 5
Blood donors and blood collection 3




*Based on graduation date.
SBB = Specialist in Blood Banking; NIH = National Institutes of Health.
Table 6. Sponsoring section for projects from SBB graduates 
from the NIH program, 1994–2019
Sponsoring section* SBB projects (N)
Laboratory Services Section
Transfusion Services Laboratory 29
HLA Laboratory 8
Cell Processing Section 8
Infectious Disease and Immunogenetics Section 4
Blood Services Section 3
Office of the Chief 3
Total 55
*Section within the Department of Transfusion Medicine.
SBB = Specialist in Blood Banking; NIH = National Institutes of Health; 
HLA = human leukocyte antigen.
Publications After Graduation
Unrelated to projects during the SBB program, 11 former 
SBB graduates (20%) authored 20 publications,20,21,24,29,32,50–65 
including two SBB graduates who contributed to current SBB 
student publications.20,24 Two SBB graduates were co-authors 
on 12 of the 20 publications,20,21,24,51–54,56,57,60–62 and three SBB 
graduates were co-authors of one publication.59
Discussion
An in-depth SBB program review including its graduate 
outcomes illuminated our accomplishments over 25 years 
and facilitated planning for the future with implementation 
of changes. As advancements were made in transfusion 
medicine, the SBB program adapted to produce graduates 
poised to become leaders in this field.
NIH has offered a wide variety of project topics to SBB 
students. From 1994 to 2019, projects in laboratory practices 
Table 7. Program value-added opportunities for SBB graduates 
from the NIH program, 1994–2019
Feature Topics Items (N) Reference
Publications ABO discrepancy 1 30
Antibody detection 1 40





ISBT 128 1 31




Platelet contamination 1 34
Platelets 1 35
Quality 1 36
Regulatory issues 2 44, 49
Serologic methods 1 45
Transfusion reaction investigation 1 33
Social media 
activities











cGMP module 1 NA
Educational posters 2 NA
SBB = Specialist in Blood Banking; NIH = National Institutes of Health; 
ISBT = International Society of Blood Transfusion; NA = not applicable; 
cGMP = current Good Manufacturing Practice.
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and immunohematology were the most common topics, 
with blood group genomics and transplantation and cellular 
engineering increasing each year. This change reflects the 
adoption of genotyping and its relevance to transfusion 
medicine, indicating that the selection of student projects has 
followed the change of current topics in the field.66 Emerging 
topics in transfusion medicine—such as the evaluation of 
transfusion triggers, the effect of age of red blood cells at time 
of transfusion, blood product management, and pathogen 
reduction—may influence future SBB projects.67–70 The steady 
presence of laboratory practice–based projects indicates that 
student projects have been and continue to be practical in 
nature.
The group activities performed in our program afforded 
students opportunities to apply new knowledge and skills 
in a safe and encouraging setting. The activities were broad 
and included writing, presenting, and auditing—all valuable 
skills toward successfully meeting the 1-year program’s 
requirements and graduating well-rounded professionals.
Many but not all SBB student projects have led to 
publication. Projects that did not lead to publication may have 
been part of a larger study, and the results of the student’s 
portion of the study, although valuable, were not enough to 
stand alone as a publication. Also, student projects involving 
verification of a process may have provided results valuable 
to the laboratory but not novel or substantial enough for pub-
lication. Other factors that may have prohibited submission 
for publication included writing ability, time constraints, and 
individual motivations of students and project mentors.
The overall SBB certification pass rate in the last 25 
years was 96 percent. SBB certification or its equivalent is 
a qualification for some job descriptions, such as supervisor 
of an AABB-accredited IRL or as education coordinator of a 
CAAHEP-accredited SBB program.2,71 For the few graduates 
who either did not pass or did not attempt the examination, 
jobs that did not require SBB certification were pursued.
A major program modification that occurred within 
the last 25 years was the switch of the program start month 
from January to July. This change allowed us to hold the 
Department of Transfusion Medicine’s two training programs, 
the Transfusion Medicine fellowship and the SBB program,1 
concurrently to share the didactic program. Before 2005, when 
students graduated in January, they could fine-tune their 
project manuscripts and time their submissions to coincide 
with the AABB Future Leaders Scholarship Award deadline in 
late summer, approximately 6 months after graduation. Since 
2006, students complete the program in July, and 1 year may 
pass before submission, if not submitted immediately after 
graduation. The increased time from graduation and new 
career obligations may be reasons why there is not 100 percent 
submission to the AABB Future Leaders Scholarship.
The number of authored papers in peer-reviewed journals 
written by our graduates totaled 20. Two of the SBB graduates 
accounted for over half of these papers. Place of employment 
post-graduation seems to influence rate of publications. 
Working in an academic research setting may influence 
SBB graduates to work on research projects and eventually 
submit publications. We limited our data collection to articles 
in PubMed post-graduation to address contributions to the 
field. There are many other worthwhile areas that we did 
not systematically capture, such as publications that are not 
listed in PubMed, participation in national and local meetings, 
volunteering as an assessor, and acting as a mentor—all 
activities that are equally important to the advancement and 
training in the field of transfusion medicine.
The SBB program has consistently graduated students 
with a high ASCP certification examination success rate over 
the past 25 years. Students conduct research projects that 
contribute to the transfusion medicine body of knowledge 
either through publication or through recognition from 
awards. Graduates find positions that allow them to use their 
SBB skills. The continued surveillance and awareness of new 
topics will continue into the coming years.
Dedication 
We would like to dedicate this article to Harvey G. Klein, 
MD, and Sherry L. Sheldon, MT(ASCP)SBB. Dr. Klein’s contri-
butions to the field of transfusion medicine over 46 years of 
government service at NIH are many, yet it is his involvement in 
the Department of Transfusion Medicine’s training programs 
that are missed after his retirement on 30 September 2019. His 
gift was the ability to ask just the right question while gently 
teaching at the same time. Sherry Sheldon worked for almost 30 
years in government service at NIH until her early retirement 
on 30 April 2017. Under Sherry’s direction and encouragement 
as SBB program director, the program produced many leaders 
in the field. Sherry helped these individuals realize their 
leadership potential. 
References
 1. Byrne KM, Sheldon SL, Flegel WA. Organization and 
management of an accredited Specialist in Blood Banking 
(SBB) technology program. Transfusion 2010;50:1612–7.
IMMUNOHEMATOLOGY, Volume 36, Number 1, 2020 11
 2. Commission on Accreditation of Allied Health Education 
Programs. Standards and Guidelines. Available from https://
w w w.caahep.org/Program-Directors/Standards.aspx. 
Accessed 8 October 2019.
 3. Bowman CA, Yu M, Cottler-Fox M. Evaluation of methods for 
preparing and thawing cryopreserved CD34+ and CD34– cell 
lines for use as reagents in flow cytometry of hematopoietic 
progenitor cells. Transfusion 1996;36:985–8.
 4. Marincola FM, Rivoltini L, Salgaller ML, Player M, Rosenberg 
SA. Differential anti-MART-1/MelanA CTL activity in 
peripheral blood of HLA-A2 melanoma patients in comparison 
to healthy donors: evidence of in vivo priming by tumor cells. J 
Immunother Emphasis Tumor Immunol 1996;19:266–77.
 5. Player MA, Barracchini KC, Simonis TB, et al. Differences in 
frequency distribution of HLA-A2 subtypes between North 
American and Italian white melanoma patients: relevance for 
epitope specific vaccination protocols. J Immunother Emphasis 
Tumor Immunol 1996;19:357–63.
 6. Chun H, Cipolone K, Procter J, Stroncek DF. Granulocyte 
storage and antigen stability. Transfusion 1999;39:983–90.
 7. Cowley H, Wojda U, Cipolone KM, Procter JL, Stroncek DF, 
Miller JL. Biotinylation modifies red cell antigens. Transfusion 
1999;39:163–8.
 8. Langston MM, Procter JL, Cipolone KM, Stroncek DF. 
Evaluation of the gel system for ABO grouping and D typing. 
Transfusion 1999;39:300–5.
 9. Kiekhaefer KM, Cipolone KM, Procter JL, Matsuo K, 
Stroncek DF. Detection of granulocyte antibodies by flow 
cytometry without the use of pure granulocyte isolates. 
Immunohematology 2001;17:70–5.
 10. Moses LA, Stroncek DF, Cipolone KM, Marincola FM. 
Detection of HLA antibodies by using flow cytometry and latex 
beads coated with HLA antigens. Transfusion 2000;40:861–6.
 11. Smith JD, Leitman SF. Filtration of RBC units: effect of storage 
time and temperature on filter performance. Transfusion 
2000;40:521–6.
 12. Stroncek DF, Carter LB, Procter JL, Dale JK, Straus SE. RBC 
autoantibodies in autoimmune lymphoproliferative syndrome. 
Transfusion 2001;41:18–23.
 13. Caruccio L, Byrne K, Procter J, Stroncek D. A novel method 
using formamide for the elution of antibodies from erythro-
cytes. Vox Sang 2002;83:63–9.
 14. Chambers DR, Procter J, Muratova O, et al. In vitro RBC 
exposure to Plasmodium falciparum has no effect on RBC 
antigen expression. Transfus Med 2002;12:213–9.
 15. Patel HD, Byrne KM, Horne M, Leitman SF, Stroncek DF. 
Factors affecting the formation of white particulate matter in 
red blood cell components. Transfusion 2005;45:1127–32.
 16. Tudisco C, Jett BW, Byrne K, Oblitas J, Leitman SF, Stroncek 
DF. The value of pH as a quality control indicator for apheresis 
platelets. Transfusion 2005;45:773–8.
 17. Greco VA, Byrne KM, Procter JL, Stroncek DF. Detection of 
antibodies in acid eluates with the gel microcolumn assay. 
Transfusion 2002;42:698–701.
 18. Stroncek DF, Rainer T, Sharon V, et al. Sickle Hb polymeriza-
tion in RBC components from donors with sickle cell trait 
prevents effective WBC reduction by filtration. Transfusion 
2002;42:1466–72.
 19. Fisher V, Khuu H, David-Ocampo V, et al. Analysis of the 
recovery of cryopreserved and thawed CD34+ and CD3+ 
cells collected for hematopoietic transplantation. Transfusion 
2014;54:1088–92.
 20. Renoud KJ, Barracchini K, Byrne KM, et al. KEL6 and KEL7 
genotyping with sequence-specific primers. Transfusion 
2006;46:1510–4.
 21. Schmid P, Huvard MJ, Lee-Stroka AH, Lee JY, Byrne KM, 
Flegel WA. Red blood cell preservation by droplet freezing 
with polyvinylpyrrolidone or sucrose-dextrose and by bulk 
freezing with glycerol. Transfusion 2011;51: 2703–8.
 22. Schmid P, Ravenell KR, Sheldon SL, Flegel WA. DARC alleles 
and Duffy phenotypes in African Americans. Transfusion 
2012;52:1260–7.
 23. Woods I, Tawab-Amiri A, Byrne K, Sabatino M, Stroncek 
DF. Pilot analysis of cytokines levels in stored granulocyte-
colony-stimulating factor-mobilized peripheral blood stem cell 
concentrates. Transfusion 2010;50: 2011–5.
 24. Ackley RJ, Lee-Stroka AH, Bryant BJ, Stroncek DF, Byrne KM. 
Cryopreserving and deglycerolizing sickle cell trait red blood 
cell components using an automated cell-processing system. 
Immunohematology 2008;24:107–12.
 25. Grose HL, Byrne KM, Salata JM, Rentas FJ, Stroncek DF. 
In vitro variables of red blood cell components collected by 
apheresis and frozen 6 and 14 days after collection. Transfusion 
2006;46:1178–83.
 26. Lodermeier MA, Byrne KM, Flegel WA. Red blood cell 
sedimentation of apheresis granulocytes. Transfusion 
2017;57:2551–2.
 27. Reese EM, Nelson RC, Flegel WA, Byrne KM, Booth GS. 
Critical value reporting in transfusion medicine: a survey of 
communication practices in U.S. facilities. Am J Clin Pathol 
2017;147:492–9.
 28. Tynuv M, Flegel WA. Quality improvement with platelet 
additive solution for safer out-of-group platelet transfusions. 
Immunohematology 2019;35:108–15.
 29. Flegel WA, Byrne KM, Klein HG. Flashback 1997: collection 
of hematopoietic progenitor cells by peripheral blood apheresis 
after stimulation with granulocyte-colony-stimulating factor. 
Transfusion 2017;57:3067–8.
 30. Ackley RJ, Byrne KM, Weddington PE. Anti-P1: don’t miss the 
obvious. Immunohematology 2007;23:130–2.
 31. Ackley RJ, Byrne KM, Weddington PE. ISBT 128: the future 
generation. Advance for Medical Laboratory Professionals. 15 
January 2007;20–3. 
 32. Ackley RJ, Byrne KM. Massive transfusion: when good patients 
go bad. Advance for Medical Laboratory Professionals. 7 April 
2008;28–31.
 33. Byrne K, Hughes VC, Procter JL, Rainer TB. Transfusion 
reaction investigation in a patient with multiple myeloma who 
has undergone a hematopoietic stem cell transplant. ASCP 
Tech Sample 2002;I–2.
 34. Byrne KM, Grose HL, Renoud KJ. Detecting platelet 
contamination: it’s in the bag. Advance for Medical Laboratory 
Professionals. 26 July 2004;18–21.
 35. Byrne KM, McGann HL, Weddington PE. Platelets: key player 
in hemostasis. Advance for Medical Laboratory Professionals. 
27 March 2006;18–21.
SBB program outcomes and graduates
12 IMMUNOHEMATOLOGY, Volume 36, Number 1, 2020
 36. Byrne KM, Pary PP, Smith CS, Zuehlke JA. Blood: it’s all about 
quality. Advance for Medical Laboratory Professionals. 10 
October 2005;25–30.
 37. Byrne KM, Shah SS, Woods IHG. Blood banking competency: 
staffing proficiency saves the day. Advance for Medical 
Laboratory Professionals. 6 October 2009;1–6. Online 
exclusive at www.advanceweb.com/MLP.
 38. Byrne KM, Tudisco CT, Patel HD. Transfusion reaction workup 
unmasks paroxysmal nocturnal hemoglobinuria in a young 
girl with acquired aplastic anemia. ASCP Tech Sample 2005; 
I–1.
 39. Patel H, Tudisco C, Byrne KM. Book review: Technical manual, 
14th edition. Immunohematology 2003;19:135–7.
 40. Byrne KM, Booth GS, Lee JY, Ravenell KR. The importance 
of antibody detection and identification in the chronically 
transfused patient. Lab Med 2010;41:261–3.
 41. Byrne KM, Bakker G, Nieves S, Pope M. Hidden treasures in 
our tool kit: "Aha" moments while resolving serological cases. 
ASCP Webcast 2010. Available from https://www.ascp.org/
content/learning.
 42. Byrne KM, Bueno MU, Pelton PB. Transfusion News Question 
of the Day 2012. Available from https://transfusionnews.com/
path-questions. Accessed 8 October 2019.
 43. Fisher VR SM, Trenblay CA, Beaulieu GP, Ward DC. 
Disseminated intravascular coagulation: laboratory support 
for management and treatment. Lab Med 2013;44:18–22.
 44. Byrne KM, Frank EG, Gedman LA, Ivey JR. They’re here! 
How to prepare your blood bank for inspection. Lab Med 
2015;46:e2–6.
 45. Byrne KM, Mercado CMC, Nnabue TN, Paige TD, Flegel WA. 
Inhibition of blood group antibodies by soluble substances. 
Immunohematology 2019;35:19–22.
 46. Byrne KM, Gedman L, Ivey JR. Transfusion News Question 
of the Day 2015. Available from https://transfusionnews.com/
path-questions. Accessed 8 October 2019.
 47. Byrne KM, Simone AR, Biggs ML. Transfusion News Question 
of the Day 2019. Available from https://transfusionnews.com/
path-questions. Accessed 8 October 2019.
 48. Byrne KM, Tynuv M, Lodermeier M. Transfusion News Question 
of the Day 2017. Available from https://transfusionnews.com/
path-questions. Accessed 8 October 2019.
 49. Byrne KM, Levy KY, Reese EM. Following the rules set by 
accreditation agencies and governing bodies to maintain 
in-compliance status: applying critical thinking skills when 
evaluating the need for change in the clinical laboratory. Lab 
Med 2016;47:e21–6.
 50. Carter LB, Procter JL, Dale JK, Straus SE, Cantilena 
CC. Description of serologic features in autoimmune 
lymphoproliferative syndrome. Transfusion 2000;40:943–8.
 51. Caruccio L, Bettinotti M, Director-Myska AE, Arthur DC, 
Stroncek D. The gene overexpressed in polycythemia rubra 
vera, PRV-1, and the gene encoding a neutrophil alloantigen, 
NB1, are alleles of a single gene, CD177, in chromosome band 
19q13.31. Transfusion 2006;46:441–7.
 52. Caruccio L, Bettinotti M, Matsuo K, Sharon V, Stroncek D. 
Expression of human neutrophil antigen-2a (NB1) is increased 
in pregnancy. Transfusion 2003;43:357–63.
 53. Caruccio L, Walkovich K, Bettinotti M, Schuller R, Stroncek D. 
CD177 polymorphisms: correlation between high-frequency 
single nucleotide polymorphisms and neutrophil surface 
protein expression. Transfusion 2004;44:77–82.
 54. Fasano RM, Monaco A, Meier ER, et al. RH genotyping in a 
sickle cell disease patient contributing to hematopoietic stem 
cell transplantation donor selection and management. Blood 
2010;116:2836–8.
 55. Griffith LM, McCoy JP Jr, Bolan CD, et al. Persistence of 
recipient plasma cells and anti-donor isohaemagglutinins 
in patients with delayed donor erythropoiesis after major 
ABO incompatible non-myeloablative haematopoietic cell 
transplantation. Br J Haematol 2005;128:668–75.
 56. Lee-Stroka H, Slezak SL, Adams S, et al. Another example 
of a KEL1 variant red cell phenotype due to a threonine to 
serine change at position 193 of Kell glycoprotein. Transfusion 
2008;48:925–9.
 57. Lim JB, Provenzano M, Kwon OH, et al. Identification of HLA-
A33-restricted CMV pp65 epitopes as common targets for 
CD8(+) CMV-specific cytotoxic T lymphocytes. Exp Hematol 
2006;34:296–307.
 58. McGann H, Wenk RE. Alloimmunization to the D antigen by a 
patient with weak D type 21. Immunohematology 2010;26:27–
9.
 59. Montemayor-Garcia C, Karagianni P, Stiles DA, et al. Genomic 
coordinates and continental distribution of 120 blood group 
variants reported by the 1000 Genomes Project. Transfusion 
2018;58:2693–704.
 60. Quillen K, Sheldon SL, Daniel-Johnson JA, Lee-Stroka AH, 
Flegel WA. A practical strategy to reduce the risk of passive 
hemolysis by screening plateletpheresis donors for high-titer 
ABO antibodies. Transfusion 2011;51:92–6.
 61. Slezak S, Jin P, Caruccio L, et al. Gene and microRNA analysis 
of neutrophils from patients with polycythemia vera and 
essential thrombocytosis: down-regulation of micro RNA-1 
and -133a. J Transl Med 2009;7:39.
 62. Stroncek DF, Caruccio L, Bettinotti M. CD177: a member of the 
Ly-6 gene superfamily involved with neutrophil proliferation 
and polycythemia vera. J Transl Med 2004;2:8.
 63. Stroncek DF, Procter JL, Moses L, et al. Intravenous 
Rh immune globulin prevents alloimmunization in D– 
granulocyte recipients but obscures the detection of an allo-
anti-K. Immunohematology 2001;17:37–41.
 64. Wenk RE, McGann H, Gibble J. Haemoglobin A1c in donor 
erythrocytes. Transfus Med 2011;21:349–50.
 65. Chen LN, Collins-Johnson N, Sapp N, et al. How do I structure 
logistic processes in preparation for outsourcing of cellular 
therapy manufacturing? Transfusion 2019;59:2506–18.
 66. Flegel WA, Castilho L, Delaney M, et al. Molecular 
immunohaematology round table discussions at the AABB 
Annual Meeting, Denver 2013. Blood Transfus 2015;13:514–
20.
 67. Flegel WA, Natanson C, Klein HG. Does prolonged storage of 
red blood cells cause harm? Br J Haematol 2014;165:3–16.
 68. McWilliams B, Triulzi DJ, Waters JH, Alarcon LH, Reddy V, 
Yazer MH. Trends in RBC ordering and use after implementing 
adaptive alerts in the electronic computerized physician order 
entry system. Am J Clin Pathol 2014;141:534–41.
K.M. Byrne et al.
IMMUNOHEMATOLOGY, Volume 36, Number 1, 2020 13
SBB program outcomes and graduates
 69. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive 
blood transfusion strategies on clinical outcomes: a meta-
analysis and systematic review. Am J Med 2014;127:124–31, 
e3.
 70. McCullough J, Goldfinger D, Gorlin J, et al. Cost implications of 
implementation of pathogen-inactivated platelets. Transfusion 
2015;55:2312–20.
 71. Kaherl K. Standards for immunohematology reference 
laboratories. Bethesda, MD: AABB, 2017.
Karen M. Byrne, MDE, MT(ASCP)SBB (corresponding author), 
Education Coordinator, Department of Transfusion Medicine, 
Clinical Center, National Institutes of Health, Building 10/ Room 
1C711, 10 Center Drive MSC 1184, Bethesda, MD 20892-1184, 
KByrne@cc.nih.gov; Traci D. Paige, MT(ASCP)SBB, Supervisor, 
Transfusion Services Laboratory, Department of Transfusion 
Medicine, Clinical Center, National Institutes of Health, Bethesda, 
MD; and Willy A. Flegel, MD, Chief, Laboratory Services Section, 
Department of Transfusion Medicine, Clinical Center, National 
Institutes of Health, Bethesda, MD.
Important Notice About Manuscripts for 
Immunohematology
Please e-mail all manuscripts to immuno@redcross.org.
Attention: SBB and BB Students
You are eligible for a free 1-year subscription to 
Immunohematology.
Ask your education supervisor to submit the name and 
complete address for each student and the inclusive dates 
of the training period to immuno@redcross.org.
Attention:  
State Blood Bank Meeting Organizers
If you are planning a state meeting and would like copies of 
Immunohematology for distribution, please send a request, 
4 months in advance, to immuno@redcross.org.
Notice to Readers
All articles published, including communications and  
book reviews, reflect the opinions of the authors and do 
not necessarily reflect the official policy of the American 
Red Cross.
